Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
FGEN - FibroGen, Inc
Market Cap 185.41M P/E - EPS this Y 65.10% Ern Qtrly Grth -
Income -168.32M Forward P/E -1.04 EPS next Y 32.40% 50D Avg Chg -79.00%
Sales 173.82M PEG - EPS past 5Y - 200D Avg Chg -88.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -93.00%
Recommedations 3.50 Quick Ratio 1.18 Shares Outstanding 100.40M 52W Low Chg 4.00%
Insider Own 0.85% ROA -26.55% Shares Float 90.52M Beta 0.70
Inst Own 56.59% ROE - Shares Shorted/Prior 4.77M/5.51M Price 1.90
Gross Margin -34.40% Profit Margin -96.84% Avg. Volume 2,806,201 Target Price 0.60
Oper. Margin -21.56% Earnings Date Nov 4 Volume 1,946,457 Change -5.00%
Healthcare | Biotechnology | United States
About FibroGen, Inc

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of locally advanced pancreatic cancer; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

FibroGen, Inc News
11/15/24 FibroGen Third Quarter 2024 Earnings: Beats Expectations
11/13/24 Q3 2024 FibroGen Inc Earnings Call
11/13/24 FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Cost Reductions
11/12/24 FibroGen (FGEN) Reports Q3 Loss, Tops Revenue Estimates
11/12/24 FibroGen: Q3 Earnings Snapshot
11/12/24 FibroGen Reports Third Quarter 2024 Financial Results
11/04/24 FibroGen to Report Third Quarter 2024 Financial Results
10/09/24 FibroGen Inc (FGEN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts
09/16/24 Duchenne muscular dystrophy: major trials and events to watch in 2023
09/03/24 FibroGen to Present at the H.C. Wainwright 26th Annual Global Investment Conference
08/09/24 FibroGen, Inc. (NASDAQ:FGEN) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
08/06/24 FibroGen (FGEN) Reports Q2 Loss, Tops Revenue Estimates
08/06/24 FibroGen: Q2 Earnings Snapshot
08/06/24 FibroGen Reports Second Quarter 2024 Financial Results and Provides Business Update
07/31/24 FibroGen axes 75% of staff after lead cancer therapy fails in Phase III trials
07/31/24 Vertex’s pain drug gets speedy FDA review; Keytruda hits a sales milestone
07/30/24 FibroGen to Report Second Quarter 2024 Financial Results
07/30/24 FibroGen Announces Topline Results from Two Late-Stage Pamrevlumab Pancreatic Cancer Studies and Provides Corporate Update
07/29/24 FibroGen, Inc. (NASDAQ:FGEN) is a favorite amongst institutional investors who own 54%
06/18/24 Favourable Signals For FibroGen: Numerous Insiders Acquired Stock
FGEN Chatroom

User Image garygb Posted - 9 hours ago

$FGEN Crazy AH drop makes price a bargain.

User Image Benfica37 Posted - 1 day ago

$FGEN Well positioned to take out .60 next week IMO.

User Image MaxMiamiFl Posted - 1 day ago

$FGEN 0.3655.....not a surprise

User Image Bwill15 Posted - 1 day ago

$FGEN this flatline at .3885-6 will be interesting to see towards the end of the day. Volume gone and what we’ve seen the last few weeks is a decline into the bell. Can she hold this level and push into the .39s again or break .40 by EOD? .37s by end of day I’d feel bearish going into next week even though this week was a win. We have to gain some solid base or we need to become pros and trading this from .32 to .40 every two weeks lol

User Image Bulldogs79 Posted - 1 day ago

$FGEN Lets go.

User Image Bulldogs79 Posted - 1 day ago

$FGEN Next leg up incoming IMO.

User Image Bwill15 Posted - 1 day ago

$FGEN she is wound tightly like a rubber band right now on the bid and ask. Sling shot engaged?? 🤞

User Image Benfica37 Posted - 1 day ago

$FGEN

User Image MaxMiamiFl Posted - 1 day ago

$FGEN $$$$$

User Image ttvenu Posted - 1 day ago

$FGEN Yay!!! The color green is on display after an eternity. Happy Friday!!

User Image arfarfman Posted - 1 day ago

$FGEN crazy because of everything else going wild I haven't noticed all the green on my shares here! I'm thinking about adding to my 40k shares, probably doubling up. Chart looks real nice over the last week after that quick market dump. Looks to have triple bottomed and matched with some recent accumulation. looking at that .60 resistance if it breaks up, then next a buck to fill that gap down. I'll be adding on any dip!

User Image Bulldogs79 Posted - 1 day ago

$FGEN

User Image BULLRUN_TRADES Posted - 1 day ago

$FGEN Im new here How much longer can this be under 1 dollar Thanks

User Image Bwill15 Posted - 1 day ago

$FGEN I feel like their Roxadustat predictions of net revenue 135-150m for the year is low. They are only 23.7M away from $150M which is their high prediction. The last two quarters have netted over $40M. I feel like 150-175M is more realistic on this trajectory. With the holidays here, 2025 will be here FAST and Q1 is pivotal for them. A lot to hopefully look forward to

User Image Bwill15 Posted - 1 day ago

$FGEN place your bets for tomorrow friends. 1. Stronger volume and reaches .43+ 2. Breaks .40 and STAYS above that line 3. Breaks .40 but ends the day RED 4. Trades choppy all day and finishes even 5. RED all day and finishes below .35

User Image MaxMiamiFl Posted - 2 days ago

$FGEN can't keep any + %

User Image Holdem_Foldem Posted - 2 days ago

$AKBA not to be morbid but the whole russia nuke thing is actually terrific for us financially 👀😭 $FGEN

User Image Bwill15 Posted - 2 days ago

$FGEN let’s see in the next 5ish trading days if we see more of a price delta than what we have seen. Usually it trades between .01 & .02 up or down throughout the day. Today we saw mid .33s to high .38s. We will see what friday brings but I have a feel we will see a .10-.15 day soon on higher volume.

User Image Bulltrader988 Posted - 2 days ago

$FGEN another 100k block at close

User Image AlarmedSheiky Posted - 2 days ago

$FGEN Normally, I swing stocks prices in this range, taking profit at 10-20%. Not this one, though. This guy is so wildly undervalued, with fundamentals so solid, I’m just going to ignore the bumps and temptations and ride it to where it is supposed to be.

User Image Bulltrader988 Posted - 2 days ago

$FGEN nice buy block, nearly 121k 👀

User Image Benfica37 Posted - 2 days ago

$FGEN Short players in control until good news PR breaks them IMO.

User Image Bwill15 Posted - 2 days ago

$FGEN

User Image BullshitBank Posted - 2 days ago

$FGEN make me millionaire?

User Image Bwill15 Posted - 2 days ago

$FGEN this stock is so fucking manipulated lololol

User Image Benfica37 Posted - 2 days ago

$FGEN Crazy undervalued. FGEN have a number of partnering opportunities for our remaining pipeline. Regaining the rights to Roxadustat from AstraZeneca in the US. And RoW excluding China and South Korea enables us to pursue internal or external development of certain indications with high end met need such as anemia in patients with lower-risk myelodysplastic syndromes. Moreover, we continue to seek partnership opportunities for our early oncology pipeline of the Phase 1, ready FG-3165 an anti-Gal9 antibody and FG-3175 an anti-CCR8 antibody lastly due to our significant US cost reduction efforts and the wind down of the parem development program. Fiber exited the third quarter in a solid cash position with $160 million in cash.

User Image Bulldogs79 Posted - 2 days ago

$FGEN Baby steps, if the stock price moves above .40 this week and holds then it can take out .50.

User Image Bwill15 Posted - 2 days ago

$FGEN hopefully non of you skippers sold on the small head fake this morning on low volume. Holds above .3650 is a win today, anything else is a cherry on top. Between now and early February is critical. A .30s price for this company is crazy when Wall Street turned its back to them, buy em up and we will celebrate later.

User Image MaxMiamiFl Posted - 2 days ago

$FGEN so 15 work days before new CEO hire announcement or merger, chapter 11, sold company, insider promotion hire, or .......all hell

User Image BullshitBank Posted - 2 days ago

$FGEN what does stock above $1 looks like? Does it look the same?

Analyst Ratings
B of A Securities Underperform Aug 8, 23
Goldman Sachs Sell Jun 27, 23
Raymond James Market Perform Jun 27, 23
B of A Securities Neutral Jun 26, 23
Stifel Hold Jun 26, 23
Raymond James Market Perform Jun 26, 23
William Blair Market Perform Jun 26, 23
Stifel Buy Jun 2, 23
Cowen & Co. Market Perform Feb 28, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Henderson Jeffrey William Director Director Sep 01 Sell 1.03 2,000 2,060 28,866 09/06/23
Henderson Jeffrey William Director Director Aug 04 Sell 1.91 2,000 3,820 30,866 08/08/23
Henderson Jeffrey William Director Director Jul 11 Sell 2.69 2,000 5,380 32,866 07/13/23
Conterno Enrique A Chief Executive Offi.. Chief Executive Officer Jul 07 Sell 2.80 1,880 5,264 374,722 07/10/23
Wettig Thane Chief Commercial Off.. Chief Commercial Officer Jun 07 Sell 17.04 1,758 29,956 109,052 06/22/23
Chung Christine SVP, China Operation.. SVP, China Operations Jun 13 Sell 17.24 12,500 215,500 236,327 06/15/23
Cravatt Benjamin Director Director Jun 07 Sell 17.13 3,944 67,561 28,736 06/09/23
Brennan Aoife Director Director Jun 07 Sell 17.13 4,733 81,076 27,947 06/09/23
Blaug Suzanne Director Director Jun 07 Sell 17.12 8,520 145,862 29,594 06/09/23
Ho Maykin Director Director Jun 07 Sell 17.24 8,520 146,885 31,501 06/09/23
EDWARDS JEFFREY L Director Director Jun 07 Sell 17.13 7,889 135,139 33,977 06/09/23
Henderson Jeffrey William Director Director Jun 07 Sell 17.28 7,000 120,960 34,866 06/09/23
Schoeneck James A Director Director Jun 07 Sell 18.03 7,100 128,013 73,722 06/09/23
Graham Juan Chief Financial Offi.. Chief Financial Officer Jun 07 Sell 16.99 1,785 30,327 71,083 06/09/23
Chung Christine SVP, China Operation.. SVP, China Operations Jun 07 Sell 17.04 3,633 61,906 248,827 06/09/23
Eisner Mark EVP, Chief Medical O.. EVP, Chief Medical Officer Jun 07 Sell 17.038 2,042 34,792 162,862 06/09/23
Conterno Enrique A Chief Executive Offi.. Chief Executive Officer Jun 07 Sell 17.04 8,897 151,605 376,602 06/09/23
Conterno Enrique A Chief Executive Offi.. Chief Executive Officer Apr 10 Sell 19.52 1,869 36,483 382,999 04/11/23
Wettig Thane Chief Commercial Off.. Chief Commercial Officer Mar 23 Sell 18.71 905 16,933 110,653 03/24/23
Chung Christine SVP, China Operation.. SVP, China Operations Mar 08 Sell 20.52 15,960 327,499 259,050 03/10/23
Conterno Enrique A Chief Executive Offi.. Chief Executive Officer Mar 08 Sell 20.52 56,261 1,154,476 384,868 03/10/23
Eisner Mark Chief Medical Office.. Chief Medical Officer Mar 08 Sell 20.52 17,503 359,162 175,176 03/10/23
Graham Juan Chief Financial Offi.. Chief Financial Officer Mar 08 Sell 20.44 7,661 156,591 72,868 03/10/23
Wettig Thane Chief Commercial Off.. Chief Commercial Officer Mar 08 Sell 20.52 13,934 285,926 111,558 03/10/23
Wettig Thane Chief Commercial Off.. Chief Commercial Officer Dec 23 Sell 15.80 734 11,597 89,163 12/28/22
Graham Juan Chief Financial Offi.. Chief Financial Officer Dec 09 Sell 14.7 2,188 32,164 47,962 12/15/22
Graham Juan Chief Financial Offi.. Chief Financial Officer Dec 08 Sell 15.16 5,741 87,034 50,150 12/15/22
Chung Christine SVP, China Operation.. SVP, China Operations Dec 08 Sell 15.79 1,096 17,306 237,705 12/09/22
Wettig Thane Chief Commercial Off.. Chief Commercial Officer Dec 08 Sell 15.79 382 6,032 89,897 12/09/22
Conterno Enrique A Chief Executive Offi.. Chief Executive Officer Dec 08 Sell 15.79 2,543 40,154 297,020 12/09/22
Kurkijarvi Kalevi Director Director Jan 21 Option 19.05 6,000 114,300 39,100 01/21/21
Kurkijarvi Kalevi Director Director Jan 21 Sell 43.38 6,000 260,280 33,100 01/21/21
Kurkijarvi Kalevi Director Director Jan 15 Option 19.05 5,999 114,281 39,099 01/15/21
Kurkijarvi Kalevi Director Director Jan 15 Sell 40.04 5,999 240,200 33,100 01/15/21
Kurkijarvi Kalevi Director Director Dec 30 Option 18.7 6,001 112,219 39,101 12/30/20
Kurkijarvi Kalevi Director Director Dec 30 Sell 40.77 6,001 244,661 33,100 12/30/20